This is our library on scientific research related to CBD, the Endocannabinoid System, other cannabinoids and Inflammation. Below you will find a list of conditions for which there are one or more scientific studies of CBD. The source of these scientific studies relates primarily to PubMed, an online service of the U.S. National Library of Medicine.

Important: The studies that are listed by PubMed are for the most part preclinical research. These relate in most cases to animal experiments with isolated CBD (pure CBD) and not fully extracted CBD extract. Although mammals have cell receptors that respond to cannabinoid compounds, the data collected from animal studies are not always 1: 1 applicable to humans. Always check with your physician before starting a new dietary supplement program. Learn more at: The Basics of CBD Oils and Cannabis as a Therapeutic Agent

Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor 
Cannabinoids in clinical practice  
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Cannabinoids, endocannabinoids, and related analogs in inflammation  
Cannabinoids, inflammation, and fibrosis
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain
Mechanisms of action of CBD in adoptively transferred experimental autoimmune encephalomyelitis
Protective effect of CBD on hydrogen peroxide‑induced apoptosis, inflammation and oxidative stress in nucleus pulposus cells
Pure THC-V inhibits nitrite production in murine peritoneal macrophages
The endocannabinoid system: an emerging key player in inflammation
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

Send this to a friend